Divis Laboratories Ltd.

Divis Laboratories Surges 8%, Hits New 52-Week High

Divis Labs Plans to Invest Rs 500 Crore to Set Up Plant

Divis Laboratories Ltd - Updates

Divis Laboratories Ltd - Fixes Book Closure for Dividend & AGM

Divis Laboratories Ltd - Resignation of Director

Divis Laboratories Ltd - FY 11 results on May 20, 2011

Divis Laboratories Ltd - Announces Q2 results

Divis Laboratories Ltd - Results Press Release

Divis Laboratories Ltd - Outcome of Committee Meeting

Divis Laboratories Ltd - Q2 results on Nov 09, 2010

Shareholding for the Period Ended June 30, 2018

Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here

Statement Of Investor Complaints For The Quarter Ended June 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disp...

Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of notice ...

Updates

Divi's Laboratories Limited has informed the Exchange regarding 'Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement...

Updates

Divi's Laboratories Limited has informed the Exchange regarding 'Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement...

Board to consider FY18 results & Dividend on May 26, 2018

Divis Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on May 26, 2018, inter-alia, to co...

Board Meeting On 26/05/2018

Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, the 26th day of May 2018, inter-alia, ...

Updates

Divi's Laboratories Limited has informed the Exchange regarding 'Divi?s Laboratories hereby announces that its Unit-I at Choutuppal, Telangana State h...

Revised Compliance Certificate For Half Year Ended 31St March 2018

We enclose herewith the revised Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2...

Shareholding for the Period Ended March 31, 2018

Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here

Statement Of Investor Complaints For The Quarter Ended March 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disp...

Compliance Certificate Under Regualtion 40(10)Of SEBI Listing Regulations

Please find enclosed Compliance Certificate as required under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, ...

Board Meeting On January 27, 2018

Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, the 27th day of January 2018 to consid...

Statement Of Investor Complaints For The Quarter Ended 31St December 2017.

In compliance with Regulation 13 (3) of SEBI (LODR) Regulations, 2015, please find below the statement of investors complaints for the quarter ended 3...

Shareholding for the Period Ended December 31, 2017

Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here

Updates

We had earlier informed the Exchanges vide our letter of 2nd November, 2017 that the US-FDA will be lifting the Import Alert 66-40 imposed on the comp...

Updates

Divi's Laboratories Limited has informed the Exchange regarding 'We had earlier informed the Exchanges vide our letter of 2nd November, 2017 that the ...

Updates

Further to our letter dated 2nd November, 2017, Divis Laboratories has been informed by the US-FDA that the Agency has completed evaluation of the Com...

Updates

Divi's Laboratories Limited has informed the Exchange regarding 'Further to our letter dated 2nd November, 2017, Divi?s Laboratories has been informed...

Updates

Divis Laboratories has been informed by the US-FDA that it will be lifting the Import Alert 66-40 and moving to close out the Warning letter issued to...